China Drug Price Reform Takes Shape: Price Ceilings Out, Reimbursement Caps In
This article was originally published in The Pink Sheet Daily
Executive Summary
China’s NDRC plans to substitute reimbursement caps for maximum ceiling prices on drugs to narrow the difference between prices of branded and domestic generics. For imported patented drugs, international reference pricing is under consideration.